8-37965350-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000025.3(ADRB3):​c.1120G>T​(p.Ala374Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000655 in 1,542,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A374T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

ADRB3
NM_000025.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.06
Variant links:
Genes affected
ADRB3 (HGNC:288): (adrenoceptor beta 3) The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.009585023).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ADRB3NM_000025.3 linkuse as main transcriptc.1120G>T p.Ala374Ser missense_variant 1/2 ENST00000345060.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ADRB3ENST00000345060.5 linkuse as main transcriptc.1120G>T p.Ala374Ser missense_variant 1/21 NM_000025.3 P1
ADRB3ENST00000520341.2 linkuse as main transcriptn.1248G>T non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000734
AC:
10
AN:
136308
Hom.:
0
AF XY:
0.0000943
AC XY:
7
AN XY:
74234
show subpopulations
Gnomad AFR exome
AF:
0.00134
Gnomad AMR exome
AF:
0.0000894
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000439
AC:
61
AN:
1390232
Hom.:
0
Cov.:
31
AF XY:
0.0000438
AC XY:
30
AN XY:
685540
show subpopulations
Gnomad4 AFR exome
AF:
0.00149
Gnomad4 AMR exome
AF:
0.0000594
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000127
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.29e-7
Gnomad4 OTH exome
AF:
0.000157
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
152168
Hom.:
0
Cov.:
33
AF XY:
0.000296
AC XY:
22
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.000893
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000869
Hom.:
0
Bravo
AF:
0.000280
ExAC
AF:
0.0000582
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 13, 2021The c.1120G>T (p.A374S) alteration is located in exon 1 (coding exon 1) of the ADRB3 gene. This alteration results from a G to T substitution at nucleotide position 1120, causing the alanine (A) at amino acid position 374 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
9.0
DANN
Uncertain
0.98
DEOGEN2
Benign
0.045
.;T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.41
T;T
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.0096
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
2.0
.;M
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.31
.;N
REVEL
Benign
0.028
Sift
Benign
0.14
.;T
Sift4G
Benign
0.56
.;T
Polyphen
0.12
.;B
Vest4
0.20
MutPred
0.19
.;Gain of phosphorylation at A374 (P = 0.0201);
MVP
0.64
MPC
0.97
ClinPred
0.013
T
GERP RS
2.3
Varity_R
0.059
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs533964715; hg19: chr8-37822868; COSMIC: COSV61461644; API